Associate Director Market Access and Public Affairs – Spain

Madrid - Spain

Monthly Salary: Not Disclosed

Posted on: 30+ days ago

Vacancies: 1 Vacancy

Job Summary

The role

ALK is seeking an Associate Director of Market Access and Public Affairs to lead our strategic response to the upcoming Spanish allergen regulation (effective January 2026). This is a unique opportunity to shape the future of allergy immunotherapy in Spain by driving access to evidence-based treatments and strengthening ALKs market leadership.

Youll play a key role in developing and executing ALKs market access and public affairs strategy working closely with Spanish and global teams consultants embassies regulatory authorities and key opinion leaders.

Key responsibilities

Lead ALKs market access strategy in Spain in response to the new allergen regulation.
Build and manage strong relationships with health authorities policymakers and regulators.
Partner with internal and external stakeholders to influence policy and drive market readiness.
Ensure timely and effective implementation of ALKs strategy across multiple product areas.
Monitor market and competitive developments and adjust plans proactively.

Your background

5 years experience in market access public affairs or regulatory policy ideally in pharma.
Proven experience in health policy transformation or regulatory engagement in Spain.
Strong network within Spanish healthcare authorities.
Fluent in Spanish and English (Italian is a plus).
Strategic thinker with strong execution and stakeholder management skills.
Collaborative adaptable and motivated by making a real impact in patient care.

Why join ALK

At ALK were on a mission to improve the lives of people with allergies and lead the transition to evidence-based allergy treatments. Join us in a pivotal role that combines strategic influence policy leadership and meaningful impact on patient health.

Required Experience:

Director

The roleALK is seeking an Associate Director of Market Access and Public Affairs to lead our strategic response to the upcoming Spanish allergen regulation (effective January 2026). This is a unique opportunity to shape the future of allergy immunotherapy in Spain by driving access to evidence-based...